Lymphatic Endothelial Cells Produce Chemokines in Response to the Lipid Nanoparticles Used in RNA Vaccines
Open Access
- 26 March 2024
- journal article
- research article
- Published by Pharmaceutical Society of Japan in Biological and Pharmaceutical Bulletin
- Vol. 47 (3) , 698-707
Abstract
RNA vaccines based on Lipid nanoparticles (LNP) were put into practical use within only one year after the global outbreak of the coronavirus disease 2019 (COVID-19). This success of RNA vaccine highlights the utility of an mRNA delivery system as a vaccination strategy. Potent immunostimulatory activity of LNPs (i.e., inflammation occurring at the injection site and the production of inflammatory cytokines) have recently been reported. However, we have only limited knowledge concerning which cells are responsible for responding to the LNPs. We report herein on in vitro chemokine production from non-immune cells in response to exposure to LNPs. In this study, SM-102, an ionizable lipid that is used in the approved RNA vaccine for the clinical usage of COVID-19 mRNA vaccine, was used. Immortalized mouse lymphatic endothelial cells (mLECs) or professional antigen presenting cells (APCs) such as RAW 264.7 monocyte/macrophage cells were incubated with LNPs that contained no mRNA. As a result, chemokines involved in the recruitment of monocytes/neutrophils were produced only by the mLECs following the LNP treatment. These findings indicate that LEC appear to serve as the cell that sends out initial signals to response LNPs.Keywords
This publication has 79 references indexed in Scilit:
- Telomerase mRNA Enhances Human Skin Engraftment for Wound HealingAdvanced Healthcare Materials, 2023
- Delivering mRNA to Secondary Lymphoid Tissues by Phosphatidylserine‐Loaded Lipid NanoparticlesAdvanced Healthcare Materials, 2022
- mRNA Vaccines Against SARS‐CoV‐2 Variants Delivered by Lipid Nanoparticles Based on Novel Ionizable LipidsAdvanced Functional Materials, 2022
- In vivo fate and intracellular trafficking of vaccine delivery systemsAdvanced Drug Delivery Reviews, 2022
- Emerging vaccine nanotechnology: From defense against infection to sniping cancerActa Pharmaceutica Sinica B, 2022
- Messenger RNA-Based Vaccines Against Infectious Diseases2020
- ICAM-1: A master regulator of cellular responses in inflammation, injury resolution, and tumorigenesisJournal of Leukocyte Biology, 2020
- Controlling timing and location in vaccinesAdvanced Drug Delivery Reviews, 2020
- Beyond migration—Chemokines in lymphocyte priming, differentiation, and modulating effector functionsJournal of Leukocyte Biology, 2018
- Essential involvement of interleukin-8 (IL-8) in acute inflammationJournal of Leukocyte Biology, 1994